Faure Elsa Madeleine, El Batti Salma, Sutter Willy, Bel Alain, Julia Pierre, Achouh Paul, Alsac Jean-Marc
Department of Vascular and Thoracic Surgery, Hôpital Carémeau, Nîmes, France; PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France.
Department of Cardiac and Vascular Surgery; Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
J Thorac Cardiovasc Surg. 2021 Nov;162(5):1467-1473. doi: 10.1016/j.jtcvs.2020.01.081. Epub 2020 Feb 19.
The treatment of complicated chronic aortic dissection remains controversial. We previously reported encouraging early results with the stent-assisted balloon-induced intimal disruption and relamination of aortic dissection (STABILISE) technique for treating complicated acute aortic dissections. However, to date there have been no specific reports on the treatment of complicated chronic aortic dissections with this technique. The aim of this study was to assess the results of the STABILISE technique to treat complicated chronic aortic dissection.
A single-center prospectively maintained database enrolled all patients hospitalized for aortic dissection at our institution. Inclusion criteria for the STABILISE procedure at the chronic stage of dissection (>3 months) were postdissection aneurysm with a diameter >55 mm or rapid aortic diameter growth >5 mm/6 months. We reviewed all patients treated for complicated chronic aortic dissection with the STABILISE technique. Patients were monitored at 3, 6, and 12 months and annually thereafter with clinical, imaging, and laboratory studies. Outcome analyses included survival, rupture, spinal cord ischemia, endoleak, morbidity (cardiac, renal, or pulmonary), reinterventions, false lumen patency, and aneurysm growth.
Between September 2015 and December 2018, 17 patients underwent a STABILISE procedure for complicated chronic aortic dissection of the descending aorta. Fifteen patients were treated for remaining chronic distal thoracoabdominal aortic dissection after acute DeBakey type I aortic dissection repair, and 2 patients were treated for chronic type B aortic dissection. The median patient age was 61 years (range, 46-67 years). The median interval between the onset of acute symptoms and the procedure was 9 months (range, 3-67 months). Indications for the STABILISE procedure were a rapidly growing dissected aortic diameter >5 mm/6 months in 13 patients and aneurysmal evolution of the descending thoracic aorta >55 mm in 4 patients. There were no cases of in-hospital death, stroke, spinal cord ischemia, ischemic colitis, or renal failure necessitating dialysis. The median duration of follow-up was 17 months (range, 5-28.5 months). At the last computed tomography scan, 15 patients (88%) had complete false lumen thrombosis of the treated thoracoabdominal aorta down to the renal arteries. None of the patients had aortic growth at treated thoracoabdominal aorta level. One patient developed a proximal type 1 endoleak and required reintervention. Regarding the untreated aortoiliac level below the renal arteries, 11 patients had persistent false lumen patency, and 1 patient developed a common iliac artery aneurysm. All the other patients had stable infrarenal aortoiliac diameters. No late deaths were reported during follow-up.
The STABILISE technique is a safe and effective means of performing immediate, complete aortic remodeling of the thoracoabdominal aorta in patients with complicated chronic aortic dissection, stabilizing the diameter of the dissected aorta.
复杂慢性主动脉夹层的治疗仍存在争议。我们之前报道了支架辅助球囊诱导内膜破裂及主动脉夹层再内膜化(STABILISE)技术治疗复杂急性主动脉夹层取得了令人鼓舞的早期结果。然而,迄今为止,尚无关于该技术治疗复杂慢性主动脉夹层的具体报道。本研究的目的是评估STABILISE技术治疗复杂慢性主动脉夹层的效果。
一个单中心前瞻性维护的数据库纳入了在我们机构因主动脉夹层住院的所有患者。夹层慢性期(>3个月)进行STABILISE手术的纳入标准为夹层后动脉瘤直径>55 mm或主动脉直径快速增长>5 mm/6个月。我们回顾了所有采用STABILISE技术治疗复杂慢性主动脉夹层的患者。在3、6和12个月时对患者进行监测,此后每年进行临床、影像学和实验室检查。结果分析包括生存、破裂、脊髓缺血、内漏、发病率(心脏、肾脏或肺部)、再次干预、假腔通畅情况及动脉瘤生长。
2015年9月至2018年12月,17例患者因降主动脉复杂慢性主动脉夹层接受了STABILISE手术。15例患者在急性DeBakey I型主动脉夹层修复后接受了残留慢性远端胸腹主动脉夹层的治疗,2例患者接受了慢性B型主动脉夹层的治疗。患者中位年龄为61岁(范围46 - 67岁)。急性症状发作至手术的中位间隔时间为9个月(范围3 - 67个月)。STABILISE手术的指征为13例患者主动脉夹层直径快速增长>5 mm/6个月,4例患者降胸主动脉动脉瘤进展>55 mm。没有发生院内死亡、中风、脊髓缺血、缺血性结肠炎或需要透析的肾衰竭病例。中位随访时间为17个月(范围5 - 28.5个月)。在最后一次计算机断层扫描时,15例患者(88%)治疗的胸腹主动脉直至肾动脉处假腔完全血栓形成。所有患者治疗的胸腹主动脉水平均无主动脉生长。1例患者出现近端I型内漏,需要再次干预。关于肾动脉以下未治疗的主髂动脉水平,11例患者假腔持续通畅,1例患者出现髂总动脉瘤。所有其他患者肾下腹主动脉直径稳定。随访期间未报告晚期死亡病例。
STABILISE技术是一种安全有效的方法,可对复杂慢性主动脉夹层患者的胸腹主动脉进行即刻、完全的主动脉重塑,稳定夹层主动脉的直径。